3D-printed reservoir-type implants containing poly(lactic acid)/poly(caprolactone) porous membranes for sustained drug delivery

被引:0
|
作者
Korelidou, Anna [1 ]
Domínguez-Robles, Juan [1 ]
Magill, Elizabeth R. [1 ]
Eleftheriadou, Magdalini [2 ]
Cornelius, Victoria A. [2 ]
Donnelly, Ryan F. [1 ]
Margariti, Andriana [2 ]
Larrañeta, Eneko [1 ]
机构
[1] School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast,BT9 7BL, United Kingdom
[2] Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast,BT9 7BL, United Kingdom
来源
Biomaterials Advances | 2022年 / 139卷
基金
欧盟地平线“2020”;
关键词
3-D printing - 3D-printing - Biodegradable membrane - Drug release - Implantable devices - Poly lactic acid - Poly(-caprolactone) - Porous membranes - Sustained drug release - Tetracycline;
D O I
暂无
中图分类号
学科分类号
摘要
Implantable drug delivery systems are an interesting alternative to conventional drug delivery systems to achieve local or systemic drug delivery. In this work, we investigated the potential of fused-deposition modelling to prepare reservoir-type implantable devices for sustained drug delivery. An antibiotic was chosen as a model molecule to evaluate the potential of this type of technology to prepare implants on-demand to provide prophylactic antimicrobial treatment after surgery. The first step was to prepare and characterize biodegradable rate-controlling porous membranes based on poly(lactic acid) (PLA) and poly(caprolactone) (PCL). These membranes were prepared using a solvent casting method. The resulting materials contained different PLA/PCL ratios. Cylindrical implants were 3D-printed vertically on top of the membranes. Tetracycline (TC) was loaded inside the implants and drug release was evaluated. The results suggested that membranes containing a PLA/PCL ratio of 50/50 provided drug release over periods of up to 25 days. On the other hand, membranes containing lower PCL content did not show a porous structure and accordingly the drug could not permeate to the same extent. The influence of different parameters on drug release was evaluated. It was established that film thickness, drug content and implant size are critical parameters as they have a direct influence on drug release kinetics. In all cases the implants were capable of providing drug release for at least 25 days. The antimicrobial properties of the implants were evaluated against E. coli and S. aureus. The resulting implants showed antimicrobial properties at day 0 and even after 21 days against both type of microorganisms. Finally, the biocompatibility of the implants was evaluated using endothelial cells. Cells exposed to implants were compared with a control group. There were no differences between both groups in terms of cell proliferation and morphology. © 2022 The Authors
引用
收藏
相关论文
共 50 条
  • [1] 3D-printed reservoir-type implants containing poly(lactic acid)/poly (caprolactone) porous membranes for sustained drug delivery
    Korelidou, Anna
    Dominguez-Robles, Juan
    Magill, Elizabeth R.
    Eleftheriadou, Magdalini
    Cornelius, Victoria A.
    Donnelly, Ryan F.
    Margariti, Andriana
    Larraneta, Eneko
    BIOMATERIALS ADVANCES, 2022, 139
  • [2] Reservoir-Type Subcutaneous Implantable Devices Containing Porous Rate Controlling Membranes for Sustained Delivery of Risperidone
    Li, Linlin
    Permana, Andi Dian
    Dominguez-Robles, Juan
    Amir, Muh Nur
    Habibie, Habibie
    Anjani, Qonita Kurnia
    Zhao, Li
    Moreno-Castellanos, Natalia
    Donnelly, Ryan F.
    Larraneta, Eneko
    ADVANCED HEALTHCARE MATERIALS, 2025,
  • [3] Degradation of 3D-printed poly(lactic acid) for biomedical applications
    Camila Beatriz de Souza Medeiros
    Bruna Louise Silva
    Antônio Marcos Medeiros
    José Daniel Diniz Melo
    Ana Paula Cysne Barbosa
    Polymer Bulletin, 2024, 81 : 6271 - 6281
  • [4] Degradation of 3D-printed poly(lactic acid) for biomedical applications
    Medeiros, Camila Beatriz de Souza
    Silva, Bruna Louise
    Medeiros, Antonio Marcos
    Melo, Jose Daniel Diniz
    Barbosa, Ana Paula Cysne
    POLYMER BULLETIN, 2024, 81 (07) : 6271 - 6281
  • [5] Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs
    Stewart, Sarah A.
    Dominguez-Robles, Juan
    McIlorum, Victoria J.
    Gonzalez, Zoilo
    Utomo, Emilia
    Mancuso, Elena
    Lamprou, Dimitrios A.
    Donnelly, Ryan F.
    Larraneta, Eneko
    MOLECULAR PHARMACEUTICS, 2020, 17 (09) : 3487 - 3500
  • [6] 3D-Printed Poly Lactic Acid Scaffolds with Tetrapod-Interlocked Structure Containing Dipyridamole
    Jun, Dae-Ryong
    Ahn, Guk-Young
    Choi, In Seong
    Yun, Tae Hoon
    Na, Kun
    Choi, Sung-Wook
    MACROMOLECULAR RESEARCH, 2020, 28 (01) : 5 - 8
  • [7] 3D-Printed Poly Lactic Acid Scaffolds with Tetrapod-Interlocked Structure Containing Dipyridamole
    Dae-Ryong Jun
    Guk-Young Ahn
    In Seong Choi
    Tae Hoon Yun
    Kun Na
    Sung-Wook Choi
    Macromolecular Research, 2020, 28 : 5 - 8
  • [8] Porous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery
    Boia, Raquel
    Dias, Paulo A. N.
    Martins, Joana M.
    Galindo-Romero, Caridad
    Aires, Ines D.
    Vidal-Sanz, Manuel
    Agudo-Barriuso, Marta
    de Sousad, Herminio C.
    Ambrosio, Antonio Francisco
    Braga, Mara E. M.
    Santiago, Ana Raquel
    JOURNAL OF CONTROLLED RELEASE, 2019, 316 : 331 - 348
  • [9] Emerging Biomedical and Clinical Applications of 3D-Printed Poly(Lactic Acid)-Based Devices and Delivery Systems
    Barcena, Allan John R.
    Ravi, Prashanth
    Kundu, Suprateek
    Tappa, Karthik
    BIOENGINEERING-BASEL, 2024, 11 (07):
  • [10] SUSTAINED DRUG DELIVERY SYSTEMS .1. PERMEABILITY OF POLY(EPSILON-CAPROLACTONE), POLY(DL-LACTIC ACID), AND THEIR COPOLYMERS
    PITT, CG
    JEFFCOAT, AR
    ZWEIDINGER, RA
    SCHINDLER, A
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1979, 13 (03): : 497 - 507